HEADER ONCOPROTEIN 11-JUL-20 6XR7 TITLE ABL ISOFORM 1B INACTIVE1 STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS ABL KINASE 1B ISOFORM, ONCOPROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.XIE,T.SALEH,P.ROSSI,C.G.KALODIMOS REVDAT 5 15-MAY-24 6XR7 1 REMARK REVDAT 4 14-JUN-23 6XR7 1 REMARK REVDAT 3 21-OCT-20 6XR7 1 JRNL REVDAT 2 14-OCT-20 6XR7 1 JRNL REVDAT 1 07-OCT-20 6XR7 0 JRNL AUTH T.XIE,T.SALEH,P.ROSSI,C.G.KALODIMOS JRNL TITL CONFORMATIONAL STATES DYNAMICALLY POPULATED BY A KINASE JRNL TITL 2 DETERMINE ITS FUNCTION. JRNL REF SCIENCE V. 370 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 33004676 JRNL DOI 10.1126/SCIENCE.ABC2754 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, PSVS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BHATTACHARYA AND MONTELIONE (PSVS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XR7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250586. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 250 UM U-15N U-2H U-1H13C ILVMAT REMARK 210 CH3 AND PHE HE12-CE12 ABL M309L/ REMARK 210 H415P VARIANT, 5 MM BETA- REMARK 210 MERCAPTOETHANOL, 25 MM SODIUM REMARK 210 PHOSPHATE, 75 MM SODIUM CHLORIDE, REMARK 210 90% H2O/10% D2O; 250 UM U-15N U- REMARK 210 2H U-1H13C ILVMAT CH3 AND PHE REMARK 210 HE12-CE12 ABL M309L/H415P, 5 MM REMARK 210 BETA-MERCAPTOETHANOL, 25 MM REMARK 210 SODIUM PHOSPHATE, 75 MM SODIUM REMARK 210 CHLORIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C TROSY AROMATIC; 2D 1H REMARK 210 -15N TROSY; 2D 1H-13C HMQC; 3D REMARK 210 15N NOESY; 3D CCH-NOESY; 3D 1H- REMARK 210 13C NOESY ALIPHATIC; 3D 1H-13C REMARK 210 NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 1100 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, I-PINE, SPARKY, TALOS, REMARK 210 TOPSPIN REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 264 -125.95 -138.93 REMARK 500 1 GLN A 271 33.96 -170.34 REMARK 500 1 TYR A 272 13.48 -143.37 REMARK 500 1 LYS A 282 -5.11 -59.59 REMARK 500 1 GLU A 294 -86.72 -72.42 REMARK 500 1 ASP A 382 29.37 -151.63 REMARK 500 1 ASP A 400 -81.77 -79.46 REMARK 500 1 PHE A 401 72.53 39.72 REMARK 500 1 MET A 407 -78.56 59.18 REMARK 500 1 ASP A 410 47.50 -90.23 REMARK 500 1 THR A 411 139.34 67.39 REMARK 500 1 ALA A 416 -79.96 58.53 REMARK 500 1 ALA A 418 37.60 -90.19 REMARK 500 1 ASP A 523 -53.92 -162.89 REMARK 500 1 GLU A 528 -174.95 64.93 REMARK 500 2 LYS A 264 -133.71 -145.60 REMARK 500 2 GLN A 271 -44.35 77.88 REMARK 500 2 GLU A 294 -139.15 60.72 REMARK 500 2 ASP A 295 -78.92 64.70 REMARK 500 2 PRO A 329 63.83 -65.57 REMARK 500 2 ASP A 382 28.42 -141.73 REMARK 500 2 MET A 407 -63.88 -152.73 REMARK 500 2 THR A 408 -68.03 -158.52 REMARK 500 2 ASP A 410 -43.35 -164.97 REMARK 500 2 TYR A 412 132.31 69.48 REMARK 500 2 THR A 413 -43.79 86.13 REMARK 500 2 ALA A 414 173.23 75.61 REMARK 500 2 HIS A 415 -75.89 -63.56 REMARK 500 2 ALA A 416 -57.31 -155.12 REMARK 500 2 PHE A 420 -58.55 -151.16 REMARK 500 2 VAL A 525 -65.44 70.83 REMARK 500 2 LYS A 527 94.52 -55.19 REMARK 500 2 GLU A 528 -49.28 -179.72 REMARK 500 2 LYS A 531 134.27 72.36 REMARK 500 3 LYS A 264 -127.27 -137.83 REMARK 500 3 GLN A 271 -65.57 -161.54 REMARK 500 3 LYS A 281 -57.80 -29.17 REMARK 500 3 LYS A 282 -6.33 -58.33 REMARK 500 3 LYS A 293 88.88 67.31 REMARK 500 3 GLU A 294 -70.12 76.76 REMARK 500 3 ASP A 295 101.18 -173.73 REMARK 500 3 MET A 297 32.22 -149.80 REMARK 500 3 GLU A 298 82.88 62.35 REMARK 500 3 ARG A 381 6.64 57.94 REMARK 500 3 ASP A 382 27.91 -154.50 REMARK 500 3 SER A 404 -161.25 -160.61 REMARK 500 3 ALA A 414 -85.62 -132.77 REMARK 500 3 ASP A 523 -62.68 -139.05 REMARK 500 3 GLU A 526 146.28 77.63 REMARK 500 3 LYS A 527 -72.95 75.82 REMARK 500 REMARK 500 THIS ENTRY HAS 344 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 516 GLN A 517 1 144.83 REMARK 500 PHE A 516 GLN A 517 2 149.05 REMARK 500 PHE A 516 GLN A 517 3 142.92 REMARK 500 PHE A 516 GLN A 517 4 138.77 REMARK 500 PHE A 516 GLN A 517 5 142.01 REMARK 500 PHE A 516 GLN A 517 6 147.33 REMARK 500 PHE A 516 GLN A 517 7 140.59 REMARK 500 PHE A 516 GLN A 517 8 144.56 REMARK 500 PHE A 516 GLN A 517 9 140.56 REMARK 500 PHE A 516 GLN A 517 10 140.29 REMARK 500 PHE A 516 GLN A 517 11 145.50 REMARK 500 PHE A 516 GLN A 517 12 143.15 REMARK 500 PHE A 516 GLN A 517 13 147.44 REMARK 500 PHE A 516 GLN A 517 14 140.48 REMARK 500 PHE A 516 GLN A 517 15 148.80 REMARK 500 PHE A 516 GLN A 517 16 148.24 REMARK 500 PHE A 516 GLN A 517 17 149.07 REMARK 500 PHE A 516 GLN A 517 18 144.73 REMARK 500 PHE A 516 GLN A 517 19 143.95 REMARK 500 PHE A 516 GLN A 517 20 146.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30771 RELATED DB: BMRB REMARK 900 DISTINCT CONFORMATIONAL STATES DYNAMICALLY POPULATED BY ABL KINASE REMARK 900 DETERMINE ITS RESPONSE TO PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES DBREF 6XR7 A 248 534 UNP P00519 ABL1_HUMAN 229 515 SEQRES 1 A 287 SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR ASP SEQRES 2 A 287 ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY SEQRES 3 A 287 GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU THR SEQRES 4 A 287 VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU VAL SEQRES 5 A 287 GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU ILE SEQRES 6 A 287 LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS THR SEQRES 7 A 287 ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET THR SEQRES 8 A 287 TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG SEQRES 9 A 287 GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA THR SEQRES 10 A 287 GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS ASN SEQRES 11 A 287 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL SEQRES 12 A 287 GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 13 A 287 SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS ALA SEQRES 14 A 287 GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SER SEQRES 15 A 287 LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL TRP SEQRES 16 A 287 ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR GLY SEQRES 17 A 287 MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL TYR SEQRES 18 A 287 GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO GLU SEQRES 19 A 287 GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA CYS SEQRES 20 A 287 TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA GLU SEQRES 21 A 287 ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SER SEQRES 22 A 287 ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS GLN GLY SEQRES 23 A 287 VAL HELIX 1 AA1 GLU A 257 THR A 259 5 3 HELIX 2 AA2 GLU A 298 ILE A 312 1 15 HELIX 3 AA3 LEU A 342 CYS A 349 1 8 HELIX 4 AA4 ASN A 355 LYS A 376 1 22 HELIX 5 AA5 PRO A 421 THR A 425 5 5 HELIX 6 AA6 ALA A 426 TYR A 432 1 7 HELIX 7 AA7 SER A 436 THR A 453 1 18 HELIX 8 AA8 ASP A 463 LYS A 473 1 11 HELIX 9 AA9 PRO A 484 TRP A 495 1 12 HELIX 10 AB1 SER A 504 PHE A 516 1 13 SHEET 1 AA1 5 ILE A 261 LYS A 266 0 SHEET 2 AA1 5 GLU A 274 TRP A 280 -1 O GLU A 277 N LYS A 264 SHEET 3 AA1 5 THR A 286 LEU A 292 -1 O VAL A 289 N TYR A 276 SHEET 4 AA1 5 PHE A 330 GLU A 335 -1 O THR A 334 N ALA A 288 SHEET 5 AA1 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333 SHEET 1 AA2 3 GLY A 340 ASN A 341 0 SHEET 2 AA2 3 CYS A 388 VAL A 390 -1 O VAL A 390 N GLY A 340 SHEET 3 AA2 3 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 SHEET 1 AA3 2 PHE A 378 ILE A 379 0 SHEET 2 AA3 2 SER A 404 ARG A 405 -1 O SER A 404 N ILE A 379 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1